文献速递颈动脉与弓上血管

颈动脉游离漂浮血栓的管理:系统综述

Management of carotid free-floating thrombus: A systematic review.
PubMed 文献 · J Vasc Surg · 2026-03-03

该系统综述检索PubMed和Embase至2025年5月,纳入11项研究共179例颈动脉游离漂浮血栓患者,评估现有治疗策略的安全性和有效性。主要终点为短期(<30天)和长期(>30天)非致死性卒中与全因死亡的复合终点。结果显示所有治疗策略均伴随相当的卒中或死亡风险,单纯抗凝治疗可能不充分,而颈动脉内膜切除术可能是有利选择。

要点

  • 单纯抗凝治疗短期死亡/卒中率为6.7%,提示可能不充分。
  • 颈动脉内膜切除术短期死亡/卒中率为2.6%,可能为更有利选择。
  • 现有文献质量低,缺乏随机对照研究,结论需谨慎解读。

核心结论

  • 所有现有治疗策略均伴随相当的卒中或死亡风险,单纯抗凝可能不充分,CEA可能更有利。

研究设计与样本

  • 系统综述检索PubMed和Embase至2025年5月,纳入11项研究共179例颈动脉游离漂浮血栓患者,无随机对照研究。

主要发现

  • 短期死亡/卒中率:单纯抗凝组6.7%(8/120),EVT组5.0%(1/20),CEA组2.6%(1/38)。
  • 单纯抗凝组短期全因死亡率为5.0%(6/120),非致死性卒中率为1.7%(2/120)。
  • 长期结局仅见于单纯抗凝组,死亡/卒中率为6.5%(3/46),包括2例死亡(4.3%)和1例卒中(2.2%)。

关键数值与推荐

  • 共识别20种治疗策略,分为单纯抗凝(67.0%)、抗凝联合血管内治疗(11.2%)、颈动脉内膜切除术(21.2%)和EVT+CEA联合(0.6%)。
  • 研究质量普遍较低,非比较研究平均MINORS评分为9,比较研究为15。

临床怎么用

  • 对于可手术患者,CEA可能较单纯抗凝更有利,但需结合个体情况谨慎选择。

局限性

  • 文献数量有限,患者样本量小,研究质量低,缺乏随机对照研究,结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A free-floating thrombus in the carotid artery (cFFT) is a high-risk vascular condition for stroke. Treatment recommendations are lacking. This systematic review aimed to identify the safety and effectiveness of existing management strategies for cFFT. METHODS: PubMed and Embase were systematically searched from inception to May 2025, using search terms including "free-floating thrombus" and "carotid," and treatment strategies. Eligible studies reported on treatment and clinical outcomes. Two authors independently screened eligible literature and extracted data. Study quality was assessed with the Methodological Index for Non-Randomized Studies score (MINORS score). Primary end points were the composite of any nonfatal stroke and all-cause death (death/stroke) at the short-term (<30 days) and long-term (>30 days) follow-up after initial treatment. RESULTS: Our literature search revealed 11 studies, encompassing 179 patients with cFFT. These studies were predominantly of low quality, with a mean MINORS score of 9 for noncomparative studies and 15 for comparative studies; notably, no randomized controlled studies were identified. Twenty treatment strategies were identified, grouped as antithrombotic medication (AM; n = 120/179 [67.0%]), or AM combined with endovascular treatment (EVT) (n = 20/179 [11.2%]), carotid endarterectomy (CEA) (n = 38/179 [21.2%]), and combined EVT + CEA (n = 1/179 [0.6%]). Sequential treatments were analyzed by timing: those initiated before 30 days contributed to short-term outcomes and those thereafter to long-term outcomes. Short-term combined death/stroke rates were reportedly highest with AM alone (n = 8/120 [6.7%]), followed by EVT (n = 1/20 [5.0%]) and CEA (n = 1/38 [2.6%]). The AM group reported a short-term all-cause death rate of 5.0% (n = 6/120) and nonfatal stroke rate of 1.7% (n = 2/120). Long-term outcomes occurred solely in the AM group, yielding a death/stroke rate of 6.5% (n = 3/46), comprising two deaths (n = 2/46, 4.3%) and one stroke (n = 1/46, 2.2%). CONCLUSIONS: The published literature on cFFT is limited and lacks high-quality studies. This review suggests that all currently reported treatment strategies are associated with a considerable risk for stroke or death. Anticoagulation alone appears to be inadequate, thereby challenging current European Society for Vascular Surgery guideline recommendations, whereas the results for CEA suggest it may represent a more favorable option in patients amenable to surgery. These findings should be interpreted with caution given the small number of patients included. Nevertheless, our data may help to inform the design of future studies and contribute to the development of more standardized treatment strategies.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Aouam O, de Bresser CJM, van Hattum ES, et al. Management of carotid free-floating thrombus: A systematic review. J Vasc Surg. 2026. PMID: 41786007. doi:10.1016/j.jvs.2026.02.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。